CRISPR THERAPEUTICS AG
Asset & Liabilities Breakdown
Asset Breakdown FY2016
Total Assets: $345.0M
Liabilities Breakdown FY2016
Total Liabilities: $112.1M
Asset Breakdown
Total Assets: $345.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $315.5M | 91.5% |
| Accounts Receivable | $3.2M | 0.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $21.0M | 6.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $399.0K | 0.1% |
| Other Assets | $4.9M | 1.4% |
Liabilities Breakdown
Total Liabilities: $112.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.6M | 4.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $107.5M | 95.9% |